已收录 270542 条政策
 政策提纲
  • 暂无提纲
Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopenia
[摘要] Purpose: The present study was designed to assess the efficacy and safety of IGNG that is a new liquid, saccharose and maltose-free highly purified ready-to-use 5% intravenous immunoglobulin (IVIg), in primary immune thrombocytopenic patients with severe
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 血液学
[关键词] Acute myeloid leukemia;elderly patients;chemotherapy;co-morbidities;hypomethylating agents;cytogenetics;hematopoietic stem cell transplantation [时效性] 
   浏览次数:31      统一登录查看全文      激活码登录查看全文